Cargando…

Novel combined single dose anti-hepatitis C therapy: a pilot study

The new anti-hepatitis C virus (HCV) molecules improve treatment regimens and outcomes, but there are drawbacks. New combinations should target the HCV infectious cycle and be effective against all HCV genotypes. We developed the novel formulation Catvira, composed of epigallocatechingallate (EGCG) ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiha, Gamal, Soliman, Reham, Elbasiony, Mohamed, Darwish, Noureldien H. E., Mousa, Shaker A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907074/ https://www.ncbi.nlm.nih.gov/pubmed/33633233 http://dx.doi.org/10.1038/s41598-021-84066-3

Ejemplares similares

Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
por: Shiha, Gamal, et al.
Publicado: (2019)

Hepatitis C virus management: potential impact of nanotechnology
por: Elberry, Mostafa H., et al.
Publicado: (2017)

Current status and future directions in the management of chronic hepatitis C
por: Aman, Wosen, et al.
Publicado: (2012)

Stem cell therapies for autoimmune hepatitis
por: Lotfy, Ahmed, et al.
Publicado: (2021)

Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone
por: El-Far, Ali H., et al.
Publicado: (2020)

Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management
por: Sudha, Thangirala, et al.
Publicado: (2021)

Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2022)

Serum Hyaluronic Acid: A Promising Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Shiha, Gamal
Publicado: (2008)

Change in the hepatic profile of hepatitis C virus genotype 4–infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study
por: Waked, Imam, et al.
Publicado: (2018)

Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt
por: Reipold, Elena Ivanova, et al.
Publicado: (2021)

Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer
por: El-Far, Ali H., et al.
Publicado: (2021)

The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs
por: Nabil, Ahmed, et al.
Publicado: (2021)

PD-L1 Expression on Circulating CD34+ Hematopoietic Stem Cells Closely Correlated with T-cell Apoptosis in Chronic Hepatitis C Infected Patients
por: Abdellatif, Hussein, et al.
Publicado: (2018)

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
por: Abdulmalik, Osheiza, et al.
Publicado: (2021)

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl(4)-Induced Liver Fibrosis
por: Shiha, Gamal, et al.
Publicado: (2020)

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt
por: Shiha, Gamal, et al.
Publicado: (2019)

Prognostic value of some inflammatory markers in patients with lymphoma
por: Hamed Anber, Nahla, et al.
Publicado: (2019)

Anticancer Effects of the Corchorus olitorius Aqueous Extract and Its Bioactive Compounds on Human Cancer Cell Lines
por: Tosoc, John Paul Sese, et al.
Publicado: (2021)

Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020
por: Nabil, Ahmed, et al.
Publicado: (2020)

Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021
por: Nabil, Ahmed, et al.
Publicado: (2021)

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
por: Sudha, Thangirala, et al.
Publicado: (2017)

High Seroprevalence of Hepatitis C Virus Antibody in Breast Cancer Patients in Egypt
por: Hussein, Osama, et al.
Publicado: (2021)

Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
por: Darwish, Noureldien H.E., et al.
Publicado: (2016)

A New Eucalyptol-Rich Lavender (Lavandula stoechas L.) Essential Oil: Emerging Potential for Therapy against Inflammation and Cancer
por: Boukhatem, Mohamed Nadjib, et al.
Publicado: (2020)

Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2019)

Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
por: Karakus, Ozlem Ozen, et al.
Publicado: (2021)

Correction: Karakus et al. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 2021, 9, 1713
por: Karakus, Ozlem Ozen, et al.
Publicado: (2022)

Evaluating the Efficacy and Safety of a Single-Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy: A Randomized Comparative Pilot Study
por: Shaker, Ehab Hanafy, et al.
Publicado: (2023)

Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
por: Sudha, Thangirala, et al.
Publicado: (2017)

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods
por: Abdalla, Ahmed F, et al.
Publicado: (2009)

Effect of direct-acting antivirals on corrected QT interval and cardiac functions in patients with chronic hepatitis C virus infection
por: Ibrahim, Mohamed Gamal, et al.
Publicado: (2020)

Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study
por: Dawood, Reham M, et al.
Publicado: (2021)

Mass screening for hepatitis B and C in Southern Upper Egypt
por: Soliman, Gamal, et al.
Publicado: (2019)

A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection
por: Saad, Yasmin, et al.
Publicado: (2014)

Prophylactic and curative anti-ulcerogenic activity and the possible mechanisms of action of some desert plants
por: El-Meligy, Reham M., et al.
Publicado: (2017)

Is Combination Therapy for Chronic Hepatitis C Toxic for Cardiac Function?
por: Almawardy, Ramzy, et al.
Publicado: (2012)

Fibrosis regression following hepatitis C antiviral therapy
por: Elsharkawy, Aisha, et al.
Publicado: (2022)

Skin Tags and Acanthosis Nigricans in Patients with Hepatitis C Infection in Relation to Insulin Resistance and Insulin Like Growth Factor-1 Levels
por: El Safoury, Omar Soliman, et al.
Publicado: (2012)

Mucin1 expression and gustatory function in postmenopausal females: A case-control observational study
por: Aggour, Reham-Lotfy, et al.
Publicado: (2022)

Occult Hepatitis C Virus Infection in Hemodialysis Patients; Single Center Study
por: El-shishtawy, Samya, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_630tso2vcacbtd8n5er6ftqvjo